LYMPHOMA: ADVANCES IN IMAGING AND RADIOTHERAPY SPECIAL FEATURE: REVIEW ARTICLE PET- guided treatment for personalised therapy of Hodgkin lymphoma and aggressive non- Hodgkin lymphoma
Affiliation
Division of Cancer Sciences, University of Manchester, Manchester, UKIssue Date
2021
Metadata
Show full item recordAbstract
FDG-PET scanning has a central role in lymphoma staging and response assessment. There is a growing body of evidence that PET response assessment during and after initial systemic therapy can provide useful prognostic information, and PET response has an evolving role in guiding patient care. This review provides a perspective on the role of PET response assessment for individualised management of patients with the most common aggressive lymphomas, Hodgkin lymphoma and diffuse large B-cell lymphoma.Citation
Phillips EH, Iype R, Wirth A. LYMPHOMA: ADVANCES IN IMAGING AND RADIOTHERAPY SPECIAL FEATURE: REVIEW ARTICLE PET- guided treatment for personalised therapy of Hodgkin lymphoma and aggressive non- Hodgkin lymphoma. British Journal of Radiology. 2021;94(1127):13.Journal
British Journal of RadiologyDOI
10.1259/bjr.20210576Additional Links
https://dx.doi.org/10.1259/bjr.20210576Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1259/bjr.20210576